Report Categories
View AllRecent Articles
View All
Mxct Stock Analysis Maxcyte Inc. Biotech Holds 0.71 Dollar Mark With Mild Daily Gain 20260401 1
EFSCP Q1 2026 Earnings Preferred Stock Steady as Common EPS Misses Estimates
Intrusion Inc INTZ Q1 2026 Earnings Earnings Miss Weighs Heavily as Revenue Data Remains Absent
DTE Q1 2026 Earnings EPS Misses Estimates as Utility Navigates Cost Pressures
Xponential Fitness Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction
GBLI Q1 2026 Earnings EPS Falls Short of Estimates as Underwriting Results Weigh
SXT Q1 2026 Earnings Strong EPS Beat Drives Positive Sentiment
RWAY Q1 2026 Earnings EPS Misses Estimates but Stock Gains as Portfolio Remains Resilient
BFLY Q1 2026 Earnings EPS Beat Surprises as Butterfly Network Posts Narrower Loss
KOSS Q1 2026 Earnings Loss Per Share Widens Amidst Challenging Retail Environment
GPRO Q1 2026 Earnings Massive EPS Miss Despite Stock Rally
SHIP Q4 2025 Earnings EPS Surpasses Estimates by 163 as Stock Slips on Broader Market Sentiment